orbifloxacin has been researched along with Infections, Staphylococcal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Odoi, A; Oguttu, JW; Qekwana, DN; Sithole, F | 1 |
| Miller, WH; Peters, J; Scott, DW | 1 |
2 other study(ies) available for orbifloxacin and Infections, Staphylococcal
| Article | Year |
|---|---|
Patterns and predictors of antimicrobial resistance among Staphylococcus spp. from canine clinical cases presented at a veterinary academic hospital in South Africa.
Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; Ciprofloxacin; Clindamycin; Dog Diseases; Dogs; Doxycycline; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Enrofloxacin; Female; Fluoroquinolones; Hospitals, Animal; Kanamycin; Lincomycin; Male; Retrospective Studies; South Africa; Spectinomycin; Staphylococcal Infections; Staphylococcus; Trimethoprim, Sulfamethoxazole Drug Combination; Tylosin | 2017 |
Efficacy of orbifloxacin tablets for the treatment of superficial and deep pyoderma due to Staphylococcus intermedius infection in dogs.
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Dog Diseases; Dogs; Female; Male; Pyoderma; Staphylococcal Infections; Time Factors; Treatment Outcome | 2006 |